highly significantP < .001
The advantage of the mRNA-1273 vaccine over each of the other 2 vaccines was highly significant ( P < .001) based on the adjusted log-rank test.
The advantage of the mRNA-1273 vaccine over each of the other 2 vaccines was highly significant ( P < .001) based on the adjusted log-rank test.